Postmarketing Surveillance of the Safety and Effectiveness of Daclatasvir and Asunaprevir for the Treatment of Chronic HCV Genotype 1B Infection in the Routine Clinical Practice in Korea
Clinical trial NCT02727933 · COMPLETED
Trial details
- NCT number
- NCT02727933
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-11-03
- Primary completion
- 2020-07-05
- Enrollment
- 1941
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.